GNRH1 and pancreatic adenocarcinoma: Data of 34 malignancies showed that GNRH1 was highly expressed in tumor tissues compared with normal tissues in 10 tumors, including KIRC, KIRP (kidney renal papillary cell carcinoma), KIPAN (pan-kidney cohort), LAML (acute myeloid leukemia), HNSC (head and neck squamous cell carcinoma), PAAD (pancreatic adenocarcinoma), and WT (high-risk Wilms tumor) (Figure 7A).